retatrutide vs orforglipron See how compares to what we currently have on the market regarding weight loss! Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Published June 23, 2023 N Engl J Next-Gen GLP-1 after Ozempic: Retatrutide

GLP-1 RA Drug Concerns Ozempic (semaglutide) is the most widely used of this new class of medications, and was originally introduced by Novo Nordisk as a treatment for Type 2 diabetes

Pharmacokinetics (Coskun et al., Cell Metabolism 2022) Phase 1 PK data established the ~6-day half-life and once-weekly dosing rationale

This is fundamentally different from oral medications where food timing affects bioavailability

Whats the average weight loss I can expect

Even regular walks, stretching, or gentle exercise can get things flowing

While newer treatments like Retatrutide are generating excitement, established options like Tirzepatide remains the current standard